FDA Center for Drug Evaluation & Research Issues Warning Letter to SnugZ USA
October 22, 2026
October 22, 2026
WASHINGTON, Oct. 22 (TNSdock) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to SnugZ USA, Inc. from its Center for Drug Evaluation and Research:
* * *
Recipient: Mr. Brandon K. Mackay, President and Chief Executive Officer, SnugZ USA, Inc., 9258 South Prosperity Road, West Jordan, UT 84081-6161, United States, bmackay@snugzusa.com
Issuing Office: Center for Drug Evaluation and Research . . .
* * *
Recipient: Mr. Brandon K. Mackay, President and Chief Executive Officer, SnugZ USA, Inc., 9258 South Prosperity Road, West Jordan, UT 84081-6161, United States, bmackay@snugzusa.com
Issuing Office: Center for Drug Evaluation and Research . . .
